No sugarcoating it: Improve diabetes screening compliance to get claims right

Why This Topic Matters

A1c testing is frequently billed, but coverage limits, documentation gaps, and payer-specific rules can lead to denials and lost revenue. Understanding the broad compliance framework helps practices reduce avoidable claim rejections and align testing claims with payer expectations.

Article Sections

1. Coverage guidance and denial context

   Introduces the claim denial problem for hemoglobin A1c testing and points to national and local coverage guidance. It sets up the compliance issues discussed throughout the article.

2. Frequency standards and timing considerations

   Reviews general testing frequency expectations for patients with diabetes and notes situations that may affect timing. The section discusses how coverage policies can vary with patient status and treatment changes.

3. Medical necessity and diagnosis support

   Addresses the need to support testing with appropriate diagnosis information. It discusses broad categories of diabetes-related diagnoses that may affect coverage and allowable testing frequency.

4. Office laboratory billing and CLIA waiver reporting

   Covers billing considerations when the test is performed in an office setting. It discusses office-lab requirements tied to waived testing status.

5. Payer-specific reporting requirements

   Describes additional reporting expectations from certain private payers and mentions the use of supplemental reporting codes. It emphasizes checking payer policies before submitting claims.